Mostrar el registro sencillo del ítem

dc.contributor.authorRos Cervera, Gonzalo
dc.contributor.otherSánchez Pellicer, Pedro
dc.date.accessioned2023-07-03T11:21:23Z
dc.date.available2023-07-03T11:21:23Z
dc.date.issued2022-10
dc.identifier.urihttp://hdl.handle.net/10952/6540
dc.descriptionRandomized, double-blind, placebo-controlled clinical trial, to evaluate a probiotic preparation efficacy administered for 12 weeks on the evolution of atopic dermatitis patients between 3 and 17 years old A total of 60 patients diagnosed with atopic dermatitis will participate in the study, who will be randomized into two treatment groups in a 1:1 ratio (30 patients per group). The intervention groups are differentiated according to the treatment to be received: probiotic or placebo of similar appearance, along with standard therapy according to clinical guidelines. The 12 weeks of treatment are structured into 4 face-to-face visits: Visit 1 (initial; week 0), Visit 2 (week 4), Visit 3 (week 8) and Visit 4 (final; week 12).es
dc.description.abstractRandomized, double-blind, placebo-controlled clinical trial, to evaluate an oral probiotic effectiveness administered as adjuvant treatment for 12 weeks on the atopic dermatitis evolution in patients between 3 and 17 years oldes
dc.language.isoenes
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectAtopic dermatitises
dc.subjectAtopic eczemaes
dc.subjectProbioticses
dc.subjectMicrobiotaes
dc.subjectMicrobiomees
dc.titleRandomized, double-blind, placebo-controlled clinical trial to evaluate a probiotic preparation efficacy as adjuvant treatment in patients between 3 and 17 years old with atopic dermatitises
dc.typeotheres
dc.rights.accessRightsopenAccesses
dc.description.disciplineCiencias de la Alimentaciónes
dc.description.disciplineMedicinaes


Ficheros en el ítem

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Attribution-NonCommercial-NoDerivatives 4.0 Internacional
Excepto si se señala otra cosa, la licencia del ítem se describe como Attribution-NonCommercial-NoDerivatives 4.0 Internacional